FDA Form 483 Dings X-Zeal on Design Validation, Reporting Procedures

The GMP Letter
A A
The FDA slapped medical device manufacturer XZeal Technologies with a Form 483, citing issues with reporting procedures and design validation.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $157.00